Literature DB >> 10842654

Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome.

L Landsberg1.   

Abstract

The pathophysiology of the various manifestations of Syndrome X has been poorly understood. A possible mechanism involves stimulation of the sympathetic nervous system (SNS). Insulin plays an important role in the relationship between dietary intake and SNS activity. Because insulin-mediated glucose uptake in central hypothalamic neurons regulates SNS activity in response to dietary intake, a hypothesis was developed that links the hyperinsulinemia of obesity to sympathetic stimulation, the latter exerting a prohypertensive effect mediated by the kidney, the heart, and the vasculature. Evidence in support of this hypothesis has been obtained from the Normative Aging Study (NAS) in which a relationship between insulin (and glucose) and the SNS, and between insulin and SNS activity and blood pressure was demonstrated. The characteristic dyslipidemia in NAS subjects, moreover, was related to insulin and epinephrine. As reported in other studies, insulin level was directly associated with low HDL and high triglyceride levels. An independent inverse association was also noted between urinary epinephrine excretion and lipid levels: high epinephrine excretion rates were associated with high HDL and low triglyceride levels and, conversely, low epinephrine excretion was associated with low HDL and high triglycerides. In the NAS, therefore, increased SNS activity contributes to hypertension while diminished adrenal medullary activity contributes to the low HDL and high triglyceride levels commonly seen in association with hypertension.

Entities:  

Mesh:

Year:  1999        PMID: 10842654     DOI: 10.1111/j.1749-6632.1999.tb07787.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  The adrenal and the metabolic syndrome.

Authors:  M S Golub
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Insulin Resistance and Urolithiasis as a Challenge for a Dietitian.

Authors:  Michalina Lubawy; Dorota Formanowicz
Journal:  Int J Environ Res Public Health       Date:  2022-06-10       Impact factor: 4.614

3.  Insulin resistance possible risk factor for cognitive impairment in fibromialgic patients.

Authors:  Antonietta Fava; Massimiliano Plastino; Dario Cristiano; Antonio Spanò; Stefano Cristofaro; Carlo Opipari; Antonio Chillà; Fatima Casalinuovo; Carmen Colica; Matteo De Bartolo; Domenico Pirritano; Domenico Bosco
Journal:  Metab Brain Dis       Date:  2013-07-28       Impact factor: 3.584

Review 4.  Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden.

Authors:  Andrea Fagiolini; K N Roy Chengappa; Isabella Soreca; Jane Chang
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  Neurogenic Obesity-Induced Insulin Resistance and Type 2 Diabetes Mellitus in Chronic Spinal Cord Injury.

Authors:  Phillip S Gordon; Gary J Farkas; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

Review 6.  Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases.

Authors:  Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2014-11-13       Impact factor: 5.156

Review 7.  The Role of Magnesium in the Pathogenesis and Treatment of Glaucoma.

Authors:  Feyzahan Ekici; Şafak Korkmaz; Emine Esra Karaca; Sabahattin Sül; Hasan Ali Tufan; Bahri Aydın; Ergin Dileköz
Journal:  Int Sch Res Notices       Date:  2014-10-13

8.  Association of insulin resistance with overactive bladder in female patients.

Authors:  Hakki Uzun; Adnan Yilmaz; Ahu Kemik; Orhan Unal Zorba; Mehmet Kalkan
Journal:  Int Neurourol J       Date:  2012-12-31       Impact factor: 2.835

9.  Carotid Arterial Stiffness and Cardiometabolic Profiles in Women with Fibromyalgia.

Authors:  Yunkyung Kim; Geun-Tae Kim; Jihun Kang
Journal:  Biomedicines       Date:  2021-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.